4892 SB
Generic Name: ropinirole
Pill imprint 4892 SB has been identified as Requip 1 mg.
Requip is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy.
Requip 1 mg is not subject to the Controlled Substances Act.
See also related documents.
Requip Images
- Generic Name:
- ropinirole
- Imprint:
-
4892
SB - Strength:
- 1 mg
- Color:
- Green
- Size:
- 8.00 mm
- Shape:
- Five-sided
- Availability:
- Prescription only
- Inactive Ingredients:
- croscarmellose sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
polyethylene glycol 400
titanium dioxide
ferric oxide yellow
indigotindisulfonate sodium
FD&C Blue No. 2
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00007-4892
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5373 | Physicians Total Care Inc (repackager) |
| 18837-0136 | Innoviant Pharmacy Inc (repackager) |
| 55289-0470 | PDRX Pharmaceuticals Inc (repackager) |
| 16590-0537 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.


